Reproducibility in Biomedical AI: A Three-Run Test of BioSkepsis, and How to Use It
An honest three-run reproducibility test of BioSkepsis, plus a practical guide to getting stable biomedical evidence per query.
BioSkepsis Blog
Latest articles, updates, and guides on AI-powered biomedical research.
How General-Purpose LLMs Are Deepening the Reproducibility Crisis in Life-Science Research
General-purpose LLMs introduce ~20% citation fabrication and 80% workflow decay in bioinformatics. See the evidence and emerging safeguards.
10 Best AI Tools for Life-Science Literature Review (2026)
The 10 best AI literature-review tools in 2026, ranked and tested — BioSkepsis, Elicit, Consensus, SciSpace, Scite & more, with top picks for biology and medicine.
AI vs Traditional Literature Review: What Changes, What Doesn't
How AI is changing literature review — what it replaces, what it augments, what it can't do, and how PRISMA methodology still applies in 2026.
Claude Connection for Biomedical Research: How to Connect Claude
Connect Claude to BioSkepsis on web, Desktop and Cowork: exact setup steps, the six PubMed research tools, and what changes for biomedical evidence questions.
10 AI Tools That Promise to Cure Disease, and Where Each Drug Pipeline
Ten AI drug discovery and precision medicine tools ranked by search demand, with the trial stage, the published data and the PMIDs behind every cure claim.
AI Tools That Molecular Tumour Boards Use for Variant Interpretation
Which AI tools molecular tumour boards use for variant interpretation: knowledge bases, MTB portals and LLMs, with concordance figures and PMIDs for each.
AI Tools Oncologists Use in 2026: Evidence and the Tumour Board Gap
A map of the AI tools oncologists use in cancer care: imaging, pathology, scribes and LLMs, what each is validated to do, and the tumour board gap left open.
Top 10 AI Tools for Clinicians at the Point of Care (2026)
Which AI tool can a clinician trust at the point of care? The 10 leading clinical AI answer engines, mapped against the PubMed evidence on diagnostic accuracy, fabricated citations and guideline concordance.
GLP-1 Receptor Agonists: The Healthspan and Longevity Evidence
What GLP-1 receptor agonists do to aging beyond weight loss: geroscience mechanisms, neuroprotection and cardiac data, and where lifespan claims break down.
SciSpace vs BioSkepsis: Which AI Tool Verifies Biomedical Citations?
SciSpace covers breadth with 280M papers. BioSkepsis covers depth with citation verification. Compare both for biomedical literature review.
What Watching Football Does to Your Body: Cortisol, Testosterone, and the Cardiovascular Physiology of Fandom
Your body thinks you are playing. BioSkepsis maps the PubMed evidence on cortisol surges, testosterone spikes, and cardiac strain in football spectators.
BioSkepsis vs Perplexity AI: Biomedical Literature Reasoning vs General AI Search Engine
Perplexity is a general-purpose AI search engine with web citations. BioSkepsis is a biomedical AI research assistant with biology-native retrieval and full-text reasoning. Feature comparison, pricing, and when to use each.
Google Scholar vs BioSkepsis — Why Biomedical Literature Needs Citation Verification, Not Just Indexing
Google Scholar indexes everything but verifies nothing. BioSkepsis grounds every claim in PubMed with citation verification. Compare both for biomedical lit review.
Pan-RAS(ON) and ROCK2 inhibition in KRAS-mutant pancreatic cancer: a mechanistic rationale for combination therapy
Mechanistic case for combining daraxonrasib (pan-RAS(ON)) with ROCK2 inhibition in KRAS-mutant PDAC: focal-adhesion resistance, EMT, and the evidence gap.
Is Aging the Source of Other Diseases? 12 Hallmarks, 120 PubMed Papers, One Pathogenic Origin
Biological aging drives cancer, neurodegeneration, and cardiovascular disease through 12 molecular hallmarks. BioSkepsis synthesised 120 PubMed papers.
BioSkepsis vs Litmaps: Biomedical Research Landscape and Citation Mapping Compared
Compare BioSkepsis and Litmaps for biomedical literature mapping. AI synthesis, citation networks, full-text analysis, and timeline visualisation compared.
BioSkepsis vs Connected Papers: Biomedical Research Landscape Mapping Compared
Compare BioSkepsis Research Landscape and Connected Papers for biomedical literature mapping. AI synthesis, citation networks, and full-text analysis compared.
Zombie Trials in Clinical Research — Prevalence, Detection, and Impact on Evidence-Based Medicine
Up to 44% of RCTs contain false data. Learn how zombie trials distort meta-analyses, inflate treatment effects by 58%, and corrupt clinical guidelines.
BioSkepsis vs Dotmatics Luma: Why Literature Intelligence and Lab Operations Are Complementary in Biomedical R&D
BioSkepsis and Dotmatics Luma serve different layers of the R&D stack. See how literature intelligence and lab operations work together.
BioSkepsis vs ERA (Google DeepMind): AI-Powered Biomedical Literature Synthesis vs Automated Scientific Code Generation
Neutral comparison of BioSkepsis and Google DeepMind's ERA for biomedical literature synthesis, computational experimentation, citation integrity, and reproducibility.
BioSkepsis vs Co-Scientist (Google DeepMind): AI-Powered Biomedical Literature Synthesis vs Autonomous Hypothesis
Neutral comparison of BioSkepsis and Google DeepMind's Co-Scientist for biomedical literature synthesis, hypothesis generation, and reproducibility.
BioSkepsis vs Robin (FutureHouse): AI-Powered Biomedical Literature Synthesis vs Autonomous Drug Discovery
Both Robin (by FutureHouse) and BioSkepsis (by EFEVRE TECH LTD) represent the vanguard of AI-driven life science acceleration. While they intersect fundamentally at literature synthesis, they approach the objective of scientific discovery from entirely different operational and structural angles. Below is a neutral side-by-side comparison of the two platforms based on peer-reviewed literature, official company releases, and tech specifications.
BioSkepsis vs OpenEvidence: Biomedical AI Research Assistant vs Clinical Decision Support for Physicians
BioSkepsis vs OpenEvidence: biology-native research assistant with 40M+ papers vs NPI-gated clinical AI for U.S. physicians. Feature comparison, use cases, and CME.
AI for invasive species risk assessment
How AI can predict, detect, and prioritize biological invasions using ecological, genomic, and remote sensing data. It highlights use cases such as early warning systems for invasive spread in climate-stressed ecosystems and real-time prioritization of biosecurity surveillance zones.
AI for Competitive Intelligence in Pharma R&D
AI for competitive intelligence in pharma R&D is a use case that applies machine learning and natural language processing to analyze scientific literature, patents, clinical trials, and regulatory data to map drug development landscapes, track competitor activity, and identify emerging technologies and therapeutic opportunities.
AI for food safety and contamination evidence reviews
A case study of how AI is applied in food safety to automate contamination evidence reviews, unify microbiology and regulatory data, and enhance risk assessment throughout the food supply chain.
AI for Ultra-Processed Food Research: How to Synthesize Evidence on UPF Health Effects
This example study explores how AI can be used to synthesize and structure fragmented scientific evidence on ultra-processed foods (UPFs) and their health effects. It outlines methods for integrating findings across nutrition science, epidemiology, and microbiome research, enabling clearer interpretation of causal mechanisms, risk pathways, and population-level outcomes. The focus is on building reproducible evidence workflows that convert heterogeneous PubMed literature into actionable insights for researchers and policy analysis.
AI for Personalized Medicine: How to Synthesize Pharmacogenomics Evidence From the Literature
This use case illustrates how AI can synthesize pharmacogenomics evidence from the scientific literature to support personalized medicine, biomarker discovery, drug response prediction, and patient-specific treatment decisions.
AI for Drug Target Validation: How to Assess Genetic, Mechanistic, and Clinical Evidence From PubMed
A use study showing how AI-based evidence synthesis helps pharma researchers assess drug targets by systematically combining genetic, mechanistic, preclinical, and clinical failure data extracted from PubMed.
AI for Drug Repurposing: How to Find New Indications in Published Literature
This use case on finding new indications in published literature shows how machine learning and natural language processing extract hidden biomedical relationships from scientific papers to identify new therapeutic uses for existing drugs. It describes the full pipeline from literature mining and knowledge graph construction to hypothesis ranking and shows how AI turns fragmented research into actionable drug repurposing opportunities.
AI for interpreting of lab results against the literature
Got a Western blot, qPCR, Seahorse, or dose-response result that contradicts what you expected? Upload it to BioSkepsis and get a citation-grounded explanation from 40M+ published biomedical papers. This use case is an example study with every mechanistic claim traced to a verified PMID. For bench scientists, PhD students, postdocs, and anyone in molecular biology, cancer research, or pharmacology who needs the published literature to make sense of confusing experimental data.
AI for building research landscape maps and finding knowledge gaps
If you are working with biomedical literature, use this BioSkepsis use case to transform scientific papers into structured research landscape maps that reveal unresolved knowledge gaps and connect mechanistic relationships across studies. It generates hypothesis-driven research directions supported by fully cited, source-grounded evidence to guide experimental design and manuscript development.
How to Validate a Preprint Prior to Journal Submission
Fact-check any preprint against 40M+ biomedical papers. Built for postdocs, PIs, peer reviewers, journal clubs, and manuscript editors who need to verify claims, citations, and effect sizes before publication.
How to Write Evidence-Based Health Content Using AI (Without Reading 50 Papers)
Cite real PubMed research in your health blog, newsletter, podcast notes, or patient education materials. For health bloggers, science communicators, medical writers, content marketers, and patient advocates.
How to Rapidly Draft a PhD Thesis Chapter with Integrated Citations
Write your thesis literature review with integrated citations from 40M+ papers. For PhD and Master's students, postdoctoral researchers, and academic supervisors in biomedicine, ecology, and agriculture.
Here's how to start your grant proposal writing
Build a citation-grounded state-of-the-art section for any grant. For PIs, postdocs, fellowship applicants, and research offices preparing NIH, ERC, Horizon Europe, or national funding proposals.
How Ultra-Processed Foods Drive Cardiovascular Disease — Fructose Metabolism, Uric Acid, and Gut Barrier Disruption
Ultra-processed foods now supply over half the daily calories in several high-income countries. Their contribution to cardiovascular disease extends far beyond energy excess through unregulated hepatic fructose metabolism, uric acid-driven mitochondrial dysfunction, and industrial additive-mediated gut barrier erosion.
PCOS Is Now PMOS: The Neuroendocrine and Metabolic Evidence Behind a Century-Long Misnomer
Searches for "PCOS new name" and "PMOS" have spiked massively since The Lancet published the rename on May 12, 2026. The old name was wrong: there are no pathological cysts, the ovaries are a target rather than the origin, and the syndrome is driven by hypothalamic KNDy neuron hyperactivity, systemic insulin resistance, and adipose-androgen feedback loops.
Hantavirus Transmission
Hantaviruses kill 35–50% of patients who develop pulmonary syndrome in the Americas — yet most infections begin with something as mundane as sweeping a dusty garage. The primary route is inhalation of aerosolized rodent urine, feces, or saliva; bites and direct contact are secondary. Here is what the peer-reviewed literature says about mechanisms, risk factors, clinical outcomes, and the current absence of a specific treatment.
Microsoft Copilot vs BioSkepsis
Microsoft Copilot is a powerful general-purpose AI assistant embedded across the Microsoft 365 ecosystem. BioSkepsis is a domain-specific research tool built to search, synthesise, and reason over 40 million+ biomedical papers. Both can answer questions — but for a life-science researcher tracking a signalling pathway or validating a drug target, the differences in how they find and ground those answers are enormous.
Preprints in Biomedical Research — What They Are, How They Work, and Why BioSkepsis Indexes Them
Preprint servers like bioRxiv and medRxiv now host hundreds of thousands of life-science manuscripts — posted before peer review, freely available to anyone. This is the guide to what preprints are, what the data says about their reliability, and how BioSkepsis handles them.
BioSkepsis AI Autopilot: Put Your Biomedical Literature Review on Autopilot
BioSkepsis operates as a standing research assistant that monitors 40M+ biomedical papers for you. Ask a natural-language question; the system retrieves, reads full texts, and synthesises an answer with passage-level citations. Unlike a general-purpose LLM, BioSkepsis makes no assertion it cannot trace to a retrieved passage.
Foundational Papers: Understand Where the Science Really Starts
Foundational Papers are the landmark studies that shaped the field you're researching. They are identified not by keyword matching or recency, but by co-citation analysis: BioSkepsis AI maps how often papers are cited together across your search results and surfaces the ones that appear at the center of that citation network.
Import from Library: Connect Your Zotero Collection to BioSkepsis AI and Unlock Literature Analysis
If you've been in research long enough, you know the feeling. Years of carefully collecting and saving papers, organized into collections that reflect your thinking, your research field, your instincts. A Zotero library is like gold for researchers, something that represents not just references, but mindful decisions behind every paper.
Master the Literature and Streamline Your Lab: How the BioSkepsis Research Feed Solves Information Overload
Stop drowning in PubMed search results. Discover how the BioSkepsis Research Feed automates literature discovery and organizes your research into actionable project feeds.
Literature Searching: A Practical Guide for Life-Science Researchers
A step-by-step practical guide to literature searching — databases, Boolean operators, MeSH, and how to spot missing evidence in biomedical research.
How to Summarise a Research Paper (With or Without AI)
A step-by-step method for summarising research papers — what to include, common mistakes, and when AI summarisers actually help (and when they don't).
How to Read Research Papers for Free (Legally) in 2026
Six legal ways to read research papers for free — PubMed Central, preprint servers, author sharing, interlibrary loan, and more.
How to Read Research Articles Efficiently (Without Missing What Matters)
Practical techniques for reading research articles efficiently without missing what matters — abstract-first, three-pass, critical-appraisal methods.